Horm Metab Res 2022; 54(02): 67-75
DOI: 10.1055/a-1725-8533
Endocrine Care

Thyroid Hormone Resistance: Multicentrical Case Series Study

Authors

  • Maria Angeles Santos Mata

    1   Hospital Maternoinfantil de Jerez, Cadiz, Spain
  • Ana Belen Ariza Jimenez

    2   Hospital Universitario Reina Sofía, Córdoba, Spain
  • Francisco Macias Lopez

    1   Hospital Maternoinfantil de Jerez, Cadiz, Spain
  • Carmen de la Camara Moraño

    2   Hospital Universitario Reina Sofía, Córdoba, Spain
Preview

Abstract

Resistance to thyroid hormone syndrome (RTHS) is defined as increased thyroxine and triiodothyronine associated with normal or increased thyrotropin. This is usually due to a pathogenic variant of the gene coding for thyroid hormone receptor B (THRB). THRB is a rare genetic disorder characterized by an altered response of target tissue to the thyroid hormone action. Retrospective cross-sectional observational study with diagnosis of RTHS evaluated in secondary and tertiary hospitals for 6 years, from 2014 to 2020, in order to describe variables including age, sex, anthropometric data, clinical and biochemical characteristics of patients, who were divided according to age, in a pediatric group from 0 to 14 years (index cases), and an adult group composed of adult relatives of index cases. A molecular analysis of the THRB gene was performed. The total retrospective cohort included 7 pediatric patients and 15 adults. We found 22 cases with a clear male predominance (14/22). Mean age is 24.8 years old (22 days-70 years). Patients were referred because of symptoms 18.2% (4/22), analysis results 22.7% (5/22), or familial study 59.1% (13/22). About 31.8% (7/22) cases show goiter, 31.8% (7/22) sympathetic symptoms and 13.6% (3/22) abnormalities in behavior. In most cases, 77.3%, (17/22) show familial background of thyroid abnormalities. It is important to remark that 18.2% (4/22) relatives received previous incorrect treatments such as thyroidectomy, because of wrong diagnosis. In conclusion, a better understanding of RTHS, its prompt molecular diagnosis and genetic counseling, could avoid unnecessary tests and inappropriate treatments.



Publikationsverlauf

Eingereicht: 25. August 2021

Angenommen nach Revision: 14. Dezember 2021

Artikel online veröffentlicht:
07. Februar 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14,70469 Stuttgart, Germany